최하영 교수
1577-5587
전문진료분야
결핵 및 호흡기 감염, 기관지확장증, 폐암
전화 예약
1577-5587
기본정보
학력
2001 ~ 2007전남대학교 의학대학 졸업 2012 ~ 2014전남대학교 대학원 의학석사 졸업 2019 ~ 2022성균관대학교 대학원 의학박사 졸업 |
경력
2007 ~ 2010공중보건의 2011 ~ 2012전남대학교병원 인턴 2012 ~ 2016전남대학교병원 레지던트 2016 ~ 2017삼성서울병원 임상강사 2017 ~ 2018한림대학교강남성심병원 호흡기내과 임상조교수 2018 ~ 2023한림대학교 의과대학 조교수 2022 ~ 2023영국 University of Dundee 연수 2023 ~ 한림대학교 의과대학 부교수 |
학회활동
2007 ~ 대한의사협회 회원 2012 ~ 대한내과학회 회원 2015 ~ 대한결핵 및 호흡기학회 회원 2017 ~ 대한중환자의학회 회원 2019 ~ 미국흉부학회 회원 2020 ~ 유럽호흡기학회 회원 2020 ~ 대한천식알레르기학회 회원 2023 ~ Editorial Board Member, European Respiratory Journal 2024 ~ Associate Editor, ERJ Open Research 2024 ~ 다제내성결핵 컨소시엄 수도권 남부권역 위원장 |
수상이력
2019 ~ 2022미래창조과학부 생애첫연구 연구비 수혜 2019Biology Research Information Center (BRIC) 선정 한국을 빛내는 사람들 2020대한결핵 및 호흡기학회 우수 초록상 2021 ~ 2026교육부 지역대학우수과학자 연구비 수혜 2021Biology Research Information Center (BRIC) 선정 한국을 빛내는 사람들 20212nd European NTM & Bronchiectasis Workshop Best Oral Presentation 2021대한결핵 및 호흡기학회 젊은 호흡기 연구자상 2022Biology Research Information Center (BRIC) 선정 한국을 빛내는 사람들(2회 선정) 2023Biology Research Information Center (BRIC) 선정 한국을 빛내는 사람들(5회 선정) 20233rd European Bronchiectasis Workshop Call For Proposal Winners 수상 2024Biology Research Information Center (BRIC) 선정 한국을 빛내는 사람들(2회 선정) 2025Biology Research Information Center (BRIC) 선정 한국을 빛내는 사람들 2025 ~ 2028교육부 글로컬 R&D 지원사업 연구비 수혜 |
논문
📌 Featured Publications (selected from >150)
1. Choi H, Richardson H, Hennayake C, Shuttleworth M, Cant E, Bottier M, Spinou A, Robertson K, Long M, De Soyza A, Ringshausen F, Goeminne P, Lorent N, Haworth C, Altenburg J, Loebinger MR, Headley D, Dicker AJ, Blasi F, Shteinberg M, Aliberti S, Polverino E, Sibila O, Shoemark A, Chalmers JD. Upper airway microbiome, mucociliary function, and clinical outcomes in bronchiectasis: Data from the EMBARC-BRIDGE study. Am J Respir Crit Care Med 2025;211:2296.
2. Choi H, Hughes C, Eke Z, Shuttleworth M, Shteinberg M, Polverino E, Goeminne PC, Welte T, Blasi F, Shoemark A, Long MB, Aliberti S, Haworth CS, Ringchausen FC, Loebinger MR, Lorent N, Chalmers JD. Clinical Efficacy of Serum Anti-glycopeptidolipid-core IgA Antibody Test for Screening Nontuberculous Mycobacterial Pulmonary Disease in Bronchiectasis: A European Multicenter Cohort Study. Chest 2025;167:1300.
3. Choi H, McShane PJ, Aliberti S, Chalmers JD. Bronchiectasis management in adults: state of the art and future directions. Eur Respir J 2024;63:2400518.
4. Choi H, Ryu S, Keir HR, Giam YH, Dicker AJ, Perea L, Richardson H, Huang JTJ, Cant E, Blasi F, Pollock J, Shteinberg M, Finch S, Aliberti S, Sibila O, Shoemark A, Chalmers JD. Inflammatory Molecular Endotypes in Bronchiectasis: A European Multicenter Cohort Study. Am J Respir Crit Care Med 2023;208:1166.
5. Chalmers JD, Aliberti S, Long MB, Xu JF, Morgan L, Choi H, Haworth C, Hull R, Spinou A, Dhar R, Daley C, McShane PJ, Thornton C, Mall MA, Chotirmall SH. Taking a wider view: The Lancet Respiratory Medicine Commission on bronchiectasis. Lancet Respir Med 2026;14:291.
6. Khor YH, Poberezhets V, Buhr RG, Chalmers JD*, Choi H*, Fan VS, George M, Holland AE, Pinnock H, Ryerson CJ, Alder R, Aronson KI, Barnes T, Benzo R, Birring SS, Boyd J, Crossley B, Flewett R, Freedman M, Gibson T, Houchen-Wolloff L, Krishnaswamy UM, Linnell J, Martinez F, Moor CC, Orr H, Pappalardo AA, Saraiva I, Wadell K, Watz H, Wijsenbeek MS, Krishnan JA, on behalf of the American Thoracic Society Assembly on Clinical Problems (* bronchiectasis/CF subcommittee co-lead). Assessment of home-based monitoring in adults with chronic lung disease: An Official American Thoracic Society Research Statement. Am J Respir Crit Care Med 2025;211:174.
7. Hull RC, Liu Y, Cao Z, Xuan KTL, de Lima Headley DA, Richardson H, Hennayake C, Lind H, McIntosh E, Pollock J, Hughes C, Viligorska K, Choi H, Gao Y, Chotirmall SH, Shoemark A, Robertson K, Burgel PR, Vendrell M, Xu X, Qu JM, Song Y, Guan WJ, Chen R, Singh S, Talwar D, Mohan BVM, Tripathi SK, Swarnakar R, Trivedi S, Goeminne PC, Shteinberg M, De Soyza A, Altenburg J, Haworth CS, Sibila O, Polverino E, Loebinger MR, Ringshausen FC, Mertsch P, Lorent N, Dimakou K, Mendez R, Mclaughlin AM, Borrill Z, Lord R, Finch S, Blasi F, Burr L, Crisafulli M, Keating R, Middleton PG, Long MB, Aliberti S, Morgan L, Dhar R, Chalmers JD, Xu JF; EMBARC, EMBARC India, Australian bronchiectasis registry and BE-China. Comorbid diabetes disease severity and microbial changes in patients with bronchiectasis: a combined analysis of data from the EMBARC, EMBARC-India, Australian, and BE-China registries. Lancet Respir Med 2026;14:620.
8. Shoemark A, Johnson ED, Shuttleworth M, Schwiening M, Hull R, Stobo J, Abo-Leyah H, Finch S, Pollock J, Huang JTJ, Richardson H, Perea L, McIntosh E, Cant E, Galloway R, Choi H, de Soyza A, Spinou A, Ringshausen FC, Lorent N, Mallia P, Johnston SL, Gierlinski M, Goeminne P, Loebinger MR, Hua Gao Y, Chotirmall SH, Dhar R, Haworth C, Altenburg J, Blasi F, Polverino E, Shteinberg M, Strickson S, Cipolla D, Teper A, Fernandez C, Shih VH, Mange K, Singanayagam A, Aliberti S, Sibila O, Long MB, Chalmers JD. Azurocidin-1 as a mediator of bronchiectasis severity, epithelial defence, and target of dipeptidyl peptidase-1 inhibition: an international, multicohort study. Lancet Respir Med 2026;14:493.
9. Sibila O, Stobo J, Perea L, Gao YH, Xu JF, Lind H, Viligorska K, Spinou A, Polverino E, Ringshausen FC, Vendrell M, Burgel PR, Haworth CS, Loebinger MR, Lorent N, Dhar R, Choi H, Chotirmall SH, De Soyza A, Hurst JR, Brown JS, van der Eerden M, Kauppi P, Johnson ED, Mendez R, Dimakou K, Elborn SJ, Goeminne PC, Aliberti S, Jayaram L, Karalus N, Taylor SL, Martin ML, Burr LD, Wong C, Terpstra L, Altenburg J, Boersma W, Chalmers JD. Symptoms, risk of future exacerbations, and response to long-term macrolide treatment in bronchiectasis: an observational study. Lancet Respir Med 2025;13:911.
10. Gao Y, Richardson H, Dicker AJ, Barton A, Kuzmanova E, Shteinberg M, Perea L, Goeminne PC, Cant E, Hennayake C, Pollock J, Abo Leyah H, Choi H, Polverino E, Blasi F, Welte T, Aliberti S, Long M, Shoemark A, Sibila O, Huang JTJ, Chalmers JD. Endotypes of Exacerbation in Bronchiectasis: An Observational Cohort Study. Am J Respir Crit Care Med 2024;210:77.
11. Cordeiro R, Choi H, Haworth CS, Chalmers JD. The Efficacy and Safety of Inhaled Antibiotics for the Treatment of Bronchiectasis in Adults: Updated Systematic Review and Meta-Analysis. Chest 2024;166:61.
1. Choi H, Richardson H, Hennayake C, Shuttleworth M, Cant E, Bottier M, Spinou A, Robertson K, Long M, De Soyza A, Ringshausen F, Goeminne P, Lorent N, Haworth C, Altenburg J, Loebinger MR, Headley D, Dicker AJ, Blasi F, Shteinberg M, Aliberti S, Polverino E, Sibila O, Shoemark A, Chalmers JD. Upper airway microbiome, mucociliary function, and clinical outcomes in bronchiectasis: Data from the EMBARC-BRIDGE study. Am J Respir Crit Care Med 2025;211:2296.
2. Choi H, Hughes C, Eke Z, Shuttleworth M, Shteinberg M, Polverino E, Goeminne PC, Welte T, Blasi F, Shoemark A, Long MB, Aliberti S, Haworth CS, Ringchausen FC, Loebinger MR, Lorent N, Chalmers JD. Clinical Efficacy of Serum Anti-glycopeptidolipid-core IgA Antibody Test for Screening Nontuberculous Mycobacterial Pulmonary Disease in Bronchiectasis: A European Multicenter Cohort Study. Chest 2025;167:1300.
3. Choi H, McShane PJ, Aliberti S, Chalmers JD. Bronchiectasis management in adults: state of the art and future directions. Eur Respir J 2024;63:2400518.
4. Choi H, Ryu S, Keir HR, Giam YH, Dicker AJ, Perea L, Richardson H, Huang JTJ, Cant E, Blasi F, Pollock J, Shteinberg M, Finch S, Aliberti S, Sibila O, Shoemark A, Chalmers JD. Inflammatory Molecular Endotypes in Bronchiectasis: A European Multicenter Cohort Study. Am J Respir Crit Care Med 2023;208:1166.
5. Chalmers JD, Aliberti S, Long MB, Xu JF, Morgan L, Choi H, Haworth C, Hull R, Spinou A, Dhar R, Daley C, McShane PJ, Thornton C, Mall MA, Chotirmall SH. Taking a wider view: The Lancet Respiratory Medicine Commission on bronchiectasis. Lancet Respir Med 2026;14:291.
6. Khor YH, Poberezhets V, Buhr RG, Chalmers JD*, Choi H*, Fan VS, George M, Holland AE, Pinnock H, Ryerson CJ, Alder R, Aronson KI, Barnes T, Benzo R, Birring SS, Boyd J, Crossley B, Flewett R, Freedman M, Gibson T, Houchen-Wolloff L, Krishnaswamy UM, Linnell J, Martinez F, Moor CC, Orr H, Pappalardo AA, Saraiva I, Wadell K, Watz H, Wijsenbeek MS, Krishnan JA, on behalf of the American Thoracic Society Assembly on Clinical Problems (* bronchiectasis/CF subcommittee co-lead). Assessment of home-based monitoring in adults with chronic lung disease: An Official American Thoracic Society Research Statement. Am J Respir Crit Care Med 2025;211:174.
7. Hull RC, Liu Y, Cao Z, Xuan KTL, de Lima Headley DA, Richardson H, Hennayake C, Lind H, McIntosh E, Pollock J, Hughes C, Viligorska K, Choi H, Gao Y, Chotirmall SH, Shoemark A, Robertson K, Burgel PR, Vendrell M, Xu X, Qu JM, Song Y, Guan WJ, Chen R, Singh S, Talwar D, Mohan BVM, Tripathi SK, Swarnakar R, Trivedi S, Goeminne PC, Shteinberg M, De Soyza A, Altenburg J, Haworth CS, Sibila O, Polverino E, Loebinger MR, Ringshausen FC, Mertsch P, Lorent N, Dimakou K, Mendez R, Mclaughlin AM, Borrill Z, Lord R, Finch S, Blasi F, Burr L, Crisafulli M, Keating R, Middleton PG, Long MB, Aliberti S, Morgan L, Dhar R, Chalmers JD, Xu JF; EMBARC, EMBARC India, Australian bronchiectasis registry and BE-China. Comorbid diabetes disease severity and microbial changes in patients with bronchiectasis: a combined analysis of data from the EMBARC, EMBARC-India, Australian, and BE-China registries. Lancet Respir Med 2026;14:620.
8. Shoemark A, Johnson ED, Shuttleworth M, Schwiening M, Hull R, Stobo J, Abo-Leyah H, Finch S, Pollock J, Huang JTJ, Richardson H, Perea L, McIntosh E, Cant E, Galloway R, Choi H, de Soyza A, Spinou A, Ringshausen FC, Lorent N, Mallia P, Johnston SL, Gierlinski M, Goeminne P, Loebinger MR, Hua Gao Y, Chotirmall SH, Dhar R, Haworth C, Altenburg J, Blasi F, Polverino E, Shteinberg M, Strickson S, Cipolla D, Teper A, Fernandez C, Shih VH, Mange K, Singanayagam A, Aliberti S, Sibila O, Long MB, Chalmers JD. Azurocidin-1 as a mediator of bronchiectasis severity, epithelial defence, and target of dipeptidyl peptidase-1 inhibition: an international, multicohort study. Lancet Respir Med 2026;14:493.
9. Sibila O, Stobo J, Perea L, Gao YH, Xu JF, Lind H, Viligorska K, Spinou A, Polverino E, Ringshausen FC, Vendrell M, Burgel PR, Haworth CS, Loebinger MR, Lorent N, Dhar R, Choi H, Chotirmall SH, De Soyza A, Hurst JR, Brown JS, van der Eerden M, Kauppi P, Johnson ED, Mendez R, Dimakou K, Elborn SJ, Goeminne PC, Aliberti S, Jayaram L, Karalus N, Taylor SL, Martin ML, Burr LD, Wong C, Terpstra L, Altenburg J, Boersma W, Chalmers JD. Symptoms, risk of future exacerbations, and response to long-term macrolide treatment in bronchiectasis: an observational study. Lancet Respir Med 2025;13:911.
10. Gao Y, Richardson H, Dicker AJ, Barton A, Kuzmanova E, Shteinberg M, Perea L, Goeminne PC, Cant E, Hennayake C, Pollock J, Abo Leyah H, Choi H, Polverino E, Blasi F, Welte T, Aliberti S, Long M, Shoemark A, Sibila O, Huang JTJ, Chalmers JD. Endotypes of Exacerbation in Bronchiectasis: An Observational Cohort Study. Am J Respir Crit Care Med 2024;210:77.
11. Cordeiro R, Choi H, Haworth CS, Chalmers JD. The Efficacy and Safety of Inhaled Antibiotics for the Treatment of Bronchiectasis in Adults: Updated Systematic Review and Meta-Analysis. Chest 2024;166:61.